Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies
about
A Novel Dimeric Inhibitor Targeting Beta2GPI in Beta2GPI/Antibody Complexes Implicated in Antiphospholipid SyndromeAnnexin A2 tetramer activates human and murine macrophages through TLR4.Tissue factor in antiphospholipid antibody-induced pregnancy loss: a pro-inflammatory molecule.Platelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APS.Effects of polyclonal IgG derived from patients with different clinical types of the antiphospholipid syndrome on monocyte signaling pathways.DAMPening inflammation by modulating TLR signalling.Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodiesNew therapeutic targets for the antiphospholipid syndrome.Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndrome.A role for Toll-like receptor mediated signals in neutrophils in the pathogenesis of the anti-phospholipid syndrome.Ribophorin II is involved in the tissue factor expression mediated by phosphatidylserine-dependent antiprothrombin antibody on monocytes.Role of tissue factor in thrombosis in antiphospholipid antibody syndrome.A polymorphism in TLR2 is associated with arterial thrombosis in a multiethnic population of patients with systemic lupus erythematosus.Antiphospholipid antibodies attenuate endothelial repair and promote neointima formation in mice.An A1-A1 mutant with improved binding and inhibition of β2GPI/antibody complexes in antiphospholipid syndrome.Pathophysiology of the antiphospholipid antibody syndrome.Interaction of β2-glycoprotein I with lipopolysaccharide leads to Toll-like receptor 4 (TLR4)-dependent activation of macrophages.Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome.Lipopolysaccharide appears to activate human endometrial endothelial cells through TLR-4-dependent and TLR-4-independent mechanismsAssociation of autoantibodies to heat-shock protein 60 with arterial vascular events in patients with antiphospholipid antibodies.Antiphospholipid-related chorea.Pathophysiological mechanisms in antiphospholipid syndromeThrombotic antiphospholipid syndrome shows strong haplotypic association with SH2B3-ATXN2 locus.Soluble analog of ApoER2 targeting beta2-glycoprotein I in immune complexes counteracts hypertension in lupus-prone mice with spontaneous antiphospholipid syndromeToll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome.Annexin A2: biology and relevance to the antiphospholipid syndrome.Tissue factor in the antiphospholipid syndrome.Recent advances in understanding antiphospholipid syndrome.European Forum on Antiphospholipid Antibodies: research in progress.C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodiesInhibition of thrombotic properties of persistent autoimmune anti-β2GPI antibodies in the mouse model of antiphospholipid syndromeThe dual role of innate immunity in the antiphospholipid syndrome.The role of LRP8 (ApoER2') in the pathophysiology of the antiphospholipid syndrome.Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?Pathogenesis of antiphospholipid syndrome: understanding the antibodies.Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis.Pathophysiology of thrombotic APS: where do we stand?Anti-β2-glycoprotein I antibodies.The role of TLR4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity.Toll-Like Receptor Pathways in Autoimmune Diseases.
P2860
Q27666379-74D30A3B-E7C3-4BF3-9DBD-D52F8B02EF14Q33608764-C2C27400-6AF1-48FC-81F9-1B9FF2865E58Q33741075-4AB08440-5287-43B6-9184-6C0E2EA0B95EQ33948737-00BB7C68-32D2-4E57-9E94-BB542606869DQ33967600-28084349-61EF-476B-8733-1B517C8338D0Q34035570-1A08EB23-3B5E-4104-B4A4-0AA2728FDE04Q34080920-142E3867-5EB5-4EC6-AF78-409056F55362Q34140319-F9522D4C-4C61-4463-9EED-13C8E11E2635Q34287356-AF459620-3E21-4609-9703-7390D0FF71A7Q34364580-F4550E13-567B-4FEE-9DFC-0F91F386ED2EQ34514845-44428F64-5A99-4970-9A6D-75075638DDA8Q34676688-EA3D7FEF-12BF-4B78-BE4A-ED5EA5EB09BDQ34722499-76EE5167-75CD-4069-927F-4F620AEF1F38Q35070716-394B4050-79C7-44FE-89F7-060F3DEBD02EQ35152055-11631396-AD8D-4035-82BD-CC8F9DDAB6EBQ35309024-9D220335-6970-420D-B40C-07A687021808Q35604834-582BF4CA-7D8E-43DD-A13C-FF1B92613C9BQ35874202-CBD16DC2-69D6-45BB-9DC0-47ABA141BF81Q36162032-E485102A-847E-4DC9-94D1-C3299250E4BAQ36300623-7D35855C-A99E-4DC5-B588-B9BA85071161Q36337350-EB4B97E3-9D47-4640-8E3B-25871FDBEB4DQ36671159-981DB0E2-A075-44F8-9274-20A7DBF03E2DQ36981341-9982894B-C2A6-40A0-A75B-26B67195795CQ37204282-AFF62D58-D8A6-490C-AC5E-EB3D2A070098Q37283036-8BCDA59F-7E75-40B9-884E-F4D7DC5AF298Q37283042-3271741D-7F70-48C0-A977-4CF95C5AB6FDQ37283046-76C83439-DB98-4457-8084-E005E10F8E2EQ37577693-49DEAFCD-1413-4894-B690-62040923C9B6Q37578126-37F3C2E8-7AE5-4EC0-94BE-AE4F3BA202EBQ37581827-CE8BDDDE-ABCA-46F6-9852-0D0F9FA9C6C6Q37585221-C8F09C8C-5129-4B50-A86E-386080D2EE35Q37721589-2AECECB9-783C-44BB-8CA7-2530E1B81D7DQ37721602-6EB58EFC-02D4-4FA6-84CE-1E459DE21656Q37721617-A2F2AB08-F93C-4843-A066-A05A4EC32FF0Q37873720-51030B65-9182-4B8C-B986-AAD5658F32F9Q37943809-65402DA6-DD7D-4E77-9286-C7DF8D8F0A60Q38013582-20A07A48-3E1E-4356-93F8-C08044E20BD5Q38108396-DA727437-2FE6-4658-AC34-C716040A48A9Q38158240-F006CBE8-5C46-4B1A-8B10-2283DB22210BQ38357504-D0E930C5-D0AB-4D05-9EC7-84CF95BF5DE1
P2860
Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies
@ast
Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies
@en
type
label
Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies
@ast
Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies
@en
prefLabel
Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies
@ast
Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies
@en
P2093
P2860
P50
P356
P1476
Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies
@en
P2093
Elena Raschi
Marco Moia
Mariano E Vega-Ostertag
Monica Galli
Silvia S Pierangeli
Tracy Nguyen-Oghalai
Valeria De Micheli
Xiaowei Liu
Zurina Romay-Penabad
P2860
P304
P356
10.1136/ARD.2006.065037
P407
P577
2007-01-29T00:00:00Z